Gross Profit: Revenues from operations less the associated costs.
Coya Therapeutics, Inc. (COYA) had Gross Profit of $0.25M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.25M |
|
$-7.21M |
|
-- |
|
|
Gross Profit |
$0.25M |
$7.89M |
|
$-7.64M |
|
$0.43M |
|
$-7.21M |
|
$-7.21M |
|
$-7.21M |
|
$-7.21M |
|
$-7.21M |
|
$-7.21M |
|
$-7.64M |
|
$-7.64M |
|
22.64M |
|
22.64M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$53.26M |
|
$0.01M |
|
$0.01M |
|
$53.27M |
|
$3.55M |
|
-- |
|
$0.75M |
|
$4.30M |
|
$48.97M |
|
$48.97M |
|
$48.97M |
|
23.46M |
|
| Cash Flow Statement Financials | |
$-6.21M |
|
$-0.89M |
|
$11.00M |
|
$46.82M |
|
$50.72M |
|
$3.90M |
|
$2.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3042.13% |
|
-3042.13% |
|
-- |
|
-2869.63% |
|
-2869.63% |
|
$-7.09M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-14.72% |
|
-14.72% |
|
-13.53% |
|
-14.72% |
|
$2.09 |
|
$-0.31 |
|
$-0.27 |
|